Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT00004915 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: raloxifene

Sponsor

Northwestern University

Collaborators

[object Object]